New Technology Capable of Prenatal Detection of 150 Genetic Syndromes From an Amniocentesis, Genetadi Biotech Reveals

Medical News Today -- Genetadi Biotech has presented to the scientific community - meeting at the XXVI National Congress on Human Genetics held in Murcia - a prenatal diagnostic device based on amniocentesis. More concretely, it is based on microarray technology (genomic hybridisation genetic chips) and with a diagnostic resolution 100 times greater than the common cytogenetic techniques. The new device, known as Amniochip, is able to detect 150 genetic genetic syndromes. "This involves currently validated genetic syndromes, including malformations and idiopathic mental deficiency not detected with a conventional kariotype", explained Ms Silvia Avila, co-director of Genetadi.